IS8354A - Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf - Google Patents

Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf

Info

Publication number: IS8354A
Authority: IS; Iceland
Prior art keywords: prostate cancer; administration; preventing prostate; intraepithelial neoplasia; preventing
Prior art date: 1998-05-07

Application number

IS8354A

Other languages

English (en)

Inventor

S. Steiner Mitchell

Raghow Sharan

Original Assignee

The University Of Tennessee Research Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-07

Filing date

2006-03-15

Publication date

2006-03-15

2006-03-15 Application filed by The University Of Tennessee Research Corporation filed Critical The University Of Tennessee Research Corporation

2006-03-15 Publication of IS8354A publication Critical patent/IS8354A/is

Links

206010060862 Prostate cancer Diseases 0.000 title abstract 2
208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
208000021046 prostate intraepithelial neoplasia Diseases 0.000 abstract 2
IWEQQRMGNVVKQW-OQKDUQJOSA-N Toremifene citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C1=CC(OCCN(C)C)=CC=C1C(\C=1C=CC=CC=1)=C(\CCCl)C1=CC=CC=C1 IWEQQRMGNVVKQW-OQKDUQJOSA-N 0.000 abstract 1
230000002113 chemopreventative effect Effects 0.000 abstract 1
229940124443 chemopreventive agent Drugs 0.000 abstract 1
239000012627 chemopreventive agent Substances 0.000 abstract 1
229960004167 toremifene citrate Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS8354A 1998-05-07 2006-03-15 Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf IS8354A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8460298P	1998-05-07	1998-05-07
PCT/US1999/010146 WO1999056739A1 (en)	1998-05-07	1999-05-07	A method for chemoprevention of prostate cancer

Publications (1)

Publication Number	Publication Date
IS8354A true IS8354A (is)	2006-03-15

Family

ID=22186034

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS5700A IS2213B (is)	1998-05-07	2000-11-01	Lyf til að meðhöndla innanþekjuæxlismyndun í blöðruhálskirtli
IS8354A IS8354A (is)	1998-05-07	2006-03-15	Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IS5700A IS2213B (is)	1998-05-07	2000-11-01	Lyf til að meðhöndla innanþekjuæxlismyndun í blöðruhálskirtli

Country Status (26)

Country	Link
US (1)	US6265448B1 (is)
EP (3)	EP1475087A3 (is)
JP (2)	JP4482229B2 (is)
AT (1)	ATE283043T1 (is)
AU (1)	AU761435B2 (is)
BG (1)	BG65597B1 (is)
CA (1)	CA2323809C (is)
CZ (1)	CZ300960B6 (is)
DE (2)	DE1003496T1 (is)
DK (1)	DK1003496T3 (is)
EA (1)	EA003466B1 (is)
ES (1)	ES2145730T3 (is)
HR (1)	HRP20000729A2 (is)
HU (1)	HUP0102068A3 (is)
IL (3)	IL138437A0 (is)
IS (2)	IS2213B (is)
NO (1)	NO20005625L (is)
NZ (1)	NZ527522A (is)
PL (1)	PL207462B1 (is)
PT (1)	PT1003496E (is)
SI (1)	SI1003496T1 (is)
SK (1)	SK16642000A3 (is)
TR (1)	TR200003269T2 (is)
UA (1)	UA74532C2 (is)
WO (1)	WO1999056739A1 (is)
YU (1)	YU68600A (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6413533B1 (en) *	1998-05-07	2002-07-02	The University Of Tennessee Research Corporation	Method for chemoprevention of prostate cancer
US20040186185A1 (en) *	1998-05-07	2004-09-23	Steiner Mitchell S.	Method for treatment and chemoprevention of prostate cancer
SI1003496T1 (en) *	1998-05-07	2005-10-31	The University Of Tennessee Research Corporation	Medicament for treating prostate intraepithelial neoplasia
US6410043B1 (en) *	1998-05-07	2002-06-25	The University Of Tennessee Research Corporation	Method for chemoprevention of prostate cancer
US20040092602A1 (en) *	1998-05-07	2004-05-13	Steiner Mitchell S.	Method for treatment and chemoprevention of prostate cancer
US20030130316A1 (en) *	2000-03-20	2003-07-10	Steiner Mitchell S.	Method for chemoprevention of prostate cancer
AU7360700A (en) *	1999-09-09	2001-04-10	Androsolutions, Inc.	Methods and compositions for preventing and treating urinary tract disorders
US6642274B1 (en)	1999-09-09	2003-11-04	Gary W. Neal	Methods and compositions for preventing and treating prostate disorders
US7524866B2 (en) *	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
US20040213841A1 (en) *	2001-11-29	2004-10-28	Steiner Mitchell S	Methods for treating hot flashes and gynecomastia
US20070197664A1 (en) *	2001-11-29	2007-08-23	Steiner Mitchell S	Prevention and treatment of androgen-deprivation induced osteoporosis
US20050080143A1 (en) *	2001-11-29	2005-04-14	Steiner Mitchell S.	Treatment of androgen-deprivation induced osteoporosis
US20060269611A1 (en) *	2001-11-29	2006-11-30	Steiner Mitchell S	Prevention and treatment of androgen-deprivation induced osteoporosis
US20080249183A1 (en) *	2001-11-29	2008-10-09	Steiner Mitchell S	Treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) *	2001-11-29	2004-05-20	Steiner Mitchell S.	Prevention and treatment of androgen-deprivation induced osteoporosis
MXPA04005112A (es)	2001-11-29	2005-04-29	Gtx Inc	Prevencion y tratamiento de osteoporosis inducida por privacion de androgeno.
US20040214898A1 (en) *	2001-11-29	2004-10-28	Steiner Mitchell S.	Methods for treating hot flashes
US7332525B2 (en) *	2003-01-17	2008-02-19	Castle Erik P	Method of treatment of prostate cancer and composition for treatment thereof
US7070816B2 (en) *	2003-12-05	2006-07-04	New Chapter, Inc.	Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US20050208159A1 (en) *	2004-03-16	2005-09-22	Kang Kyung S	Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
US20060019989A1 (en) *	2004-07-21	2006-01-26	Steiner Mitchell S	Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
US20060105045A1 (en) *	2004-11-08	2006-05-18	Buchanan Charles M	Cyclodextrin solubilizers for liquid and semi-solid formulations
WO2006052922A2 (en) *	2004-11-08	2006-05-18	Eastman Chemical Company	Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
US20060270641A1 (en) *	2005-05-31	2006-11-30	Steiner Mitchell S	Method for chemoprevention of prostate cancer
USD969722S1 (en)	2021-09-28	2022-11-15	Wagner Delima	Stabilizing wedge pad

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4329364A (en)	1974-09-11	1982-05-11	Schering Corporation	Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US4474813A (en)	1980-10-24	1984-10-02	Schering Corporation	Pharmaceutical preparations comprising flutamide
GB2126576B (en) *	1982-06-25	1985-06-19	Farmos Group Limited	Alkane and alkene derivatives
FI77839C (fi) *	1982-05-27	1989-05-10	Farmos Oy	Foerfarande foer framstaellning av nya terapeutiskt effektiva trifenylalkan- och alkenderivat.
US5491173A (en)	1982-06-25	1996-02-13	Orion-Yhtyma Oy	Tri-phenyl alkene derivatives and their preparation and use
US5595985A (en)	1989-03-10	1997-01-21	Endorecherche Inc.	Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US4990538A (en)	1989-08-23	1991-02-05	Harris Adrian L	Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs
GB9126209D0 (en)	1991-12-10	1992-02-12	Orion Yhtymae Oy	Drug formulations for parenteral use
GB9207437D0 (en)	1992-04-03	1992-05-20	Orion Yhtymae Oy	Topical administration of toremifene and its metabolites
DK0671909T3 (da) *	1992-12-01	2001-03-19	Biotie Therapies Corp	Syndecanstimulering af cellulær differentiering
US5595722A (en)	1993-01-28	1997-01-21	Neorx Corporation	Method for identifying an agent which increases TGF-beta levels
DE69435137D1 (de)	1993-05-13	2008-10-16	Poniard Pharmaceuticals Inc	Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
CA2168584C (en)	1993-08-09	2008-10-14	Edward Baral	A method for sensitization of cancer cells for killer cell mediated lysis
US5650425A (en)	1994-04-04	1997-07-22	Pharmos Corporation	Permanently ionic derivatives of steroid hormones and their antagonists
US5629007A (en)	1995-03-21	1997-05-13	Eli Lilly And Company	Method of preventing prostatic cancer development
US5635197A (en)	1995-03-21	1997-06-03	Eli Lilly And Company	Treatment and prevention of prostatic cancer metastasis
ZA984650B (en) *	1997-06-19	1998-12-08	Orion Corp	Intratumoral administration of triphenylethylenes for the treatment of cancer
SI1003496T1 (en) *	1998-05-07	2005-10-31	The University Of Tennessee Research Corporation	Medicament for treating prostate intraepithelial neoplasia

1999
- 1999-05-07 SI SI9930740T patent/SI1003496T1/xx unknown
- 1999-05-07 ES ES99924157T patent/ES2145730T3/es not_active Expired - Lifetime
- 1999-05-07 EP EP04018861A patent/EP1475087A3/en not_active Withdrawn
- 1999-05-07 DK DK99924157T patent/DK1003496T3/da active
- 1999-05-07 EP EP10012242A patent/EP2277514A1/en not_active Withdrawn
- 1999-05-07 WO PCT/US1999/010146 patent/WO1999056739A1/en not_active Ceased
- 1999-05-07 EA EA200000100A patent/EA003466B1/ru not_active IP Right Cessation
- 1999-05-07 DE DE1003496T patent/DE1003496T1/de active Pending
- 1999-05-07 YU YU68600A patent/YU68600A/sh unknown
- 1999-05-07 AU AU40726/99A patent/AU761435B2/en not_active Ceased
- 1999-05-07 DE DE69922131T patent/DE69922131T2/de not_active Expired - Lifetime
- 1999-05-07 IL IL13843799A patent/IL138437A0/xx unknown
- 1999-05-07 CA CA002323809A patent/CA2323809C/en not_active Expired - Fee Related
- 1999-05-07 SK SK1664-2000A patent/SK16642000A3/sk unknown
- 1999-05-07 NZ NZ527522A patent/NZ527522A/xx unknown
- 1999-05-07 EP EP99924157A patent/EP1003496B1/en not_active Expired - Lifetime
- 1999-05-07 TR TR2000/03269T patent/TR200003269T2/xx unknown
- 1999-05-07 HU HU0102068A patent/HUP0102068A3/hu unknown
- 1999-05-07 US US09/306,958 patent/US6265448B1/en not_active Expired - Fee Related
- 1999-05-07 AT AT99924157T patent/ATE283043T1/de not_active IP Right Cessation
- 1999-05-07 CZ CZ20004118A patent/CZ300960B6/cs not_active IP Right Cessation
- 1999-05-07 JP JP2000546766A patent/JP4482229B2/ja not_active Expired - Lifetime
- 1999-05-07 HR HR20000729A patent/HRP20000729A2/hr not_active Application Discontinuation
- 1999-05-07 PT PT99924157T patent/PT1003496E/pt unknown
- 1999-05-07 PL PL344000A patent/PL207462B1/pl not_active IP Right Cessation
- 1999-07-05 UA UA2000116229A patent/UA74532C2/uk unknown
2000
- 2000-09-12 IL IL138437A patent/IL138437A/en not_active IP Right Cessation
- 2000-11-01 IS IS5700A patent/IS2213B/is unknown
- 2000-11-07 NO NO20005625A patent/NO20005625L/no not_active Application Discontinuation
- 2000-12-05 BG BG105022A patent/BG65597B1/bg unknown
2006
- 2006-03-15 IS IS8354A patent/IS8354A/is unknown
2008
- 2008-03-21 JP JP2008074318A patent/JP2008163048A/ja active Pending
- 2008-08-04 IL IL193231A patent/IL193231A0/en unknown

Also Published As

Publication number	Publication date
WO1999056739A1 (en)	1999-11-11
EA200000100A1 (ru)	2000-08-28
CZ20004118A3 (cs)	2002-07-17
IS5700A (is)	2000-11-01
ES2145730T3 (es)	2005-06-16
NO20005625L (no)	2001-01-05
YU68600A (sh)	2003-12-31
IL138437A (en)	2008-12-29
DK1003496T3 (da)	2005-04-04
EP1475087A3 (en)	2007-07-11
DE69922131T2 (de)	2005-11-24
JP4482229B2 (ja)	2010-06-16
CA2323809A1 (en)	1999-11-11
EP1475087A2 (en)	2004-11-10
EP1003496B1 (en)	2004-11-24
SI1003496T1 (en)	2005-10-31
PL207462B1 (pl)	2010-12-31
AU761435B2 (en)	2003-06-05
PT1003496E (pt)	2005-04-29
AU4072699A (en)	1999-11-23
PL344000A1 (en)	2001-09-10
NO20005625D0 (no)	2000-11-07
EA003466B1 (ru)	2003-06-26
TR200003269T2 (tr)	2001-02-21
DE1003496T1 (de)	2000-11-02
IL138437A0 (en)	2001-10-31
ES2145730T1 (es)	2000-07-16
EP2277514A1 (en)	2011-01-26
SK16642000A3 (sk)	2002-08-06
DE69922131D1 (de)	2004-12-30
HRP20000729A2 (en)	2001-06-30
IS2213B (is)	2007-03-15
HUP0102068A3 (en)	2002-11-28
EP1003496A1 (en)	2000-05-31
BG105022A (bg)	2001-07-31
US6265448B1 (en)	2001-07-24
UA74532C2 (en)	2006-01-16
JP2002513755A (ja)	2002-05-14
ATE283043T1 (de)	2004-12-15
JP2008163048A (ja)	2008-07-17
BG65597B1 (bg)	2009-02-27
CZ300960B6 (cs)	2009-09-23
CA2323809C (en)	2007-09-18
NZ527522A (en)	2005-04-29
HUP0102068A2 (hu)	2002-05-29
IL193231A0 (en)	2009-02-11

Publication	Publication Date	Title
IS5700A (is)	2000-11-01	Aðferð til að koma í veg fyrir krabbamein í blöðruhálskirtli með lyfjagjöf
CA2289202A1 (en)	1998-11-12	Solid pharmaceutical formulations containing a physical mixture of sulfoalkyl ether cyclodextrin and a therapeutic agent
ES2163736T3 (es)	2002-02-01	Composicion herbicida sinergica y metodo para el control de malas hierbas.
DE69811233D1 (de)	2003-03-13	Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
BR0200155A (pt)	2002-10-15	Tratamento combinado para depressão
BR0114576A (pt)	2004-07-27	Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
BR0012908A (pt)	2002-04-30	Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
BR9806118A (pt)	1999-08-31	Processos para tratamento de pigmentação de pele
IL140848A (en)	2005-05-17	Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
SE0102843D0 (sv)	2001-08-27	Stabilized oral pharmaceutical composition containing lodide and lodate and method
WO2001052897A3 (en)	2002-03-14	Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors
EP0240131A3 (en)	1989-11-15	Tamoxifen for topical use
NO20010052D0 (no)	2001-01-04	NAALADase inhibitorer anvendbare som farmasöytiske forbindelser og preparater
BR0208411A (pt)	2004-03-30	Composto, composição farmacêutica tópica e método para tratamento profilático ou terapêutico de doenças sexualmente transmitidas em um paciente humano, e, uso de um composto
WO2001041751A3 (en)	2002-09-06	Phytoestrogens for treating als
HU911928D0 (en)	1991-12-30	Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
BR0006082C1 (pt)	2001-08-07	Resina epóxi, polifenol glicidilado de um fenol e glioxal,e composição
MXPA03006359A (es)	2004-04-20	Metodo para tratamiento del cancer.
NZ510445A (en)	2003-01-31	A method for intrahepatic administration of methoxymorpholino doxorubicin (MMDX) to achieve a high concentration at a hepatic tumour site
AU4650001A (en)	2001-11-20	Agent for coloring fibers and method for temporarily coloring fibers
WO2002094183A3 (en)	2003-02-27	A method for tumor treatment with fumagillol derivatives
WO2003024394A3 (en)	2003-11-20	Method of treating benign prostatic hyperplasia and other beingn porstate conditions
MX9304565A (es)	1994-04-29	Composiciones de perbromuro inorganico y metodos para su uso.
GR1003205B (el)	1999-09-03	Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37)
UA39418A (uk)	2001-06-15	Спосіб лікування виразкової хвороби, асоційованої з helicobacter pylori